ArticleAsian Pacific journal of cancer prevention : APJCP2025
A Case-Control Study on Combined Effects of Base Excision Repair and Nucleotide Excision Repair Gene Polymorphisms in Gastrointestinal Cancer Susceptibility.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal (GI) cancer constitute a major global health problem influenced by genetic and environmental factors. Genetic variations within base excision repair (BER and) nucleotide exchange repair (NER) pathway genes can impact DNA repair capacity. Investigating the combined effects of BER and NER pathway genes offers a promising avenue for understanding their impact on cancer susceptibility. This study was aimed to address combined effects of genetic variants in BER and NER on the risk of developing GI cancer.
methodsGenetic polymorphisms within BER and NER genes were examined in two hundred histologically confirmed GI cancer cases, along with equal number of controls by the PCR-RFLP technique. Odds ratios (OR) with 95% CI and associated p-values were computed to assess an extent of association of these polymorphisms with GI cancer susceptibility, with statistical significance established at p ≤0.005.
resultsRegression analysis revealed compelling evidence of synergistic effects between specific variant genotypes. Notably, combinations involving variants of XPG (rs17655) and XRCC1 (rs1799782) (OR=2.20; 95% CI: 1.02-4.72; p=0.042) and XRCC1 (rs25487) (OR=2.56; 95% CI: 1.39-4.72; p=0.002) as well as XPD (rs238406) and XRCC1 (rs1799782) (OR=3.02; 95% CI: 1.60-5.70; p=0.0006) and XCC1 (rs25487) (OR=6.63; 95% CI: 3.63-12.10; p=0.0001) exhibited significant associations with increased GI cancer risk within the study population.
conclusionThese findings suggested combined influence of SNPs within XRCC1, XRCC3, and APE1, in combination with polymorphisms of XPC and XPD, on the development of GI cancer. Nonetheless, further investigations on larger scale are warranted to validate and expand upon these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.